Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Study reports new mechanism that regulates specification of lymphocytes

Scientists at an Academy of Finland Centre of Excellence have discovered a new mechanism regulating the immune response that can leave a person susceptible to autoimmune diseases.

28 Jun 2013

Hospira receives positive opinion from EMA's CHMP for EC approval of Inflectra

Hospira, the world's leading provider of injectable drugs and infusion technologies, today received a positive opinion from the European Medicines Agency Committee for Medicinal Products for Human Use, recommending the European Commission approval of Inflectra (infliximab) for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.

28 Jun 2013

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Janssen Biotech, Inc. and Johnson & Johnson Innovation announced today the establishment of a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next generation therapeutic solutions.

27 Jun 2013

Manchester researchers launch new project to better understand causes of RA

Researchers in Manchester have this week launched an innovative new project working with patients and their families to better understand the causes of rheumatoid arthritis.

27 Jun 2013

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

MorphoSys AG and Celgene Corporation today announced an agreement to jointly develop MOR202 globally and to co-promote MOR202 in Europe.

27 Jun 2013

Karo Bio extends research collaboration with Pfizer on RORgamma modulators

Karo Bio AB announced today the extension of its existing research collaboration with Pfizer Inc. on RORgamma modulators to the end of 2014. Pfizer will continue to provide full funding for the research costs.

26 Jun 2013

Researchers provide new revelations about intricate pathways involved in turning on T cells

A major study from researchers at the La Jolla Institute for Allergy and Immunology provides new revelations about the intricate pathways involved in turning on T cells, the body's most important disease-fighting cells, and was published today in the prestigious scientific journal Nature.

24 Jun 2013

TSRI scientists find dual inhibitor that attacks two enzymes associated with Parkinson's disease

Scientists from the Florida campus of The Scripps Research Institute have found a compound that could counter Parkinson's disease in two ways at once.

21 Jun 2013

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.

18 Jun 2013

Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

The painful rheumatic condition gout is often associated with the big toe, but it turns out that patients at highest risk of further flare-ups are those whose gout first involved other joints, such as a knee or elbow, Mayo Clinic has found.

15 Jun 2013

MemoryShape Breast Implants receive FDA approval

The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age.

15 Jun 2013

EULAR announces recipients of Meritorious Service Award

EULAR today announced the recipients of the 13th annual Meritorious Service Award at the opening of the European League Against Rheumatism Annual Congress.

14 Jun 2013

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that overweight and obese patients are less likely to achieve successful remission in early rheumatoid arthritis compared to those of normal weight.

14 Jun 2013

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Study reports new mechanism that regulates specification of lymphocytes

Hospira receives positive opinion from EMA's CHMP for EC approval of Inflectra

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Manchester researchers launch new project to better understand causes of RA

MorphoSys, Celgene agree to jointly develop MOR202 for patients with multiple myeloma

Karo Bio extends research collaboration with Pfizer on RORgamma modulators

Researchers provide new revelations about intricate pathways involved in turning on T cells

TSRI scientists find dual inhibitor that attacks two enzymes associated with Parkinson's disease

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

Mayo researchers find rheumatic condition gout may be due to flare-ups in other joints

MemoryShape Breast Implants receive FDA approval

EULAR announces recipients of Meritorious Service Award

Overweight, obese ERA patients require twice as much drug therapy to achieve successful remission

Novel antibody biomarkers could significantly improve diagnosis in RA, study shows

Data demonstrate benefits of nurse-led programme on patient self-management of RA

AMPLE trial demonstrates similar safety profiles and efficacy between abatacept and adalimumab in RA

Ustekinumab doses improve signs and symptoms of PsA with favourable safety profiles

Study demonstrates efficacy of ARASHI method at evaluating radiographic joint damage in RA

TSRI scientists find emotion-related brain region plays major role in sustaining cocaine addiction

One-third of RA patients discontinue therapy within the first year of treatment

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in